Metformin Zentiva

Metformin, the active ingredient in Metformin Zentiva, is a biguanide presented as an oral dosage form for oral use. It is used to improve glycaemic control in adults with type 2 diabetes mellitus and may be prescribed as part of a comprehensive diabetes management plan.

GNH USA supplies Metformin Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Zentiva is indicated for conditions within the diabetes mellitus disease family where glucose regulation is required.

Type 2 diabetes mellitus: improves blood glucose control when combined with diet and exercise. Prediabetes (impaired fasting glucose): helps delay progression to overt diabetes. Polycystic ovary syndrome (off‑label): may improve insulin resistance and menstrual regularity.

Metformin may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite. - Diarrhea: frequent loose stools, especially during treatment initiation. - Metallic taste: transient alteration in taste perception. - Flatulence: increased intestinal gas. - Vitamin B12 deficiency: reduced absorption with long‑term use. - Weight loss: modest reduction in body weight.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hypoglycaemia: uncommon when used alone, but possible with other glucose‑lowering agents. - Pancreatitis: inflammation of the pancreas. - Anemia: due to folate deficiency.

When prescribing Metformin, clinicians should consider several safety aspects.

Renal function: assess eGFR before initiation and periodically thereafter. Lactic acidosis risk: avoid in patients with significant hepatic impairment or severe heart failure. Alcohol consumption: limit intake to reduce lactic acidosis risk. Pregnancy and lactation: discuss potential benefits and risks with the healthcare provider. Drug interactions: review concomitant medications that may affect renal clearance. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metformin may interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Iodinated contrast media: can precipitate acute renal failure and lactic acidosis. - Cimetidine: may increase metformin plasma concentrations. - Nitrates: combined use may raise the risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycaemia. - Diuretics: can affect renal function and metformin clearance. - ACE inhibitors or ARBs: monitor renal function and electrolytes during combined therapy.